No steroid

PreclinicalSmall molecule

SServices Hospital, Lahore

No steroid is one of 6 small molecule programs targeting Urethral stricture. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Urethral StrictureActive, not recruiting

Urethral StricturePreclinical

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Urethral Stricture

#DrugCompanyPhaseTrials

Mitosol

Marcaine

Mitomycin C

GGynecologic Oncology Group

Phase 3

1 4

Xiaflex

GGrupo Espanol de Tumores Neuroendocrinos

Phase 2

—5

Steroid Drug

PPeking Union Medical College Hospital

Preclinical

1 6

No steroid

SServices Hospital, Lahore

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Urethral stricture1 trial

Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy

Completed·SServices Hospital, Lahore·N/A·NCT05069883·180 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for No steroid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — No steroid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for No steroid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Services Hospital, Lahore company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SServices Hospital, Lahore

No steroid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Urethral stricture1 trial

References

Drug Info

Quick Facts

Related News